Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026 
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 
Bank of America's $72.5M Epstein Settlement: What You Need to Know 
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment 
Apple Turns 50: From Garage Startup to AI Crossroads 
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand 
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments 
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure 
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs 
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears 
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
PORT WASHINGTON, N.Y., Dec. 20, 2016 -- ACETO Corporation (NASDAQ:ACET), an international company engaged in the development, marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, today announced that management will participate in two investor conferences.
- CJS Securities "New Ideas for the New Year" Investor Conference on Wednesday, January 11, 2017 in New York City, NY. Douglas Roth, Senior Vice President and CFO, will provide an overview of the company, discuss its competitive position and its strategies for growth and will hold one-on-one meetings at the conference throughout the day.
- 35th Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2017 in San Francisco, California. Salvatore Guccione, President and CEO, is scheduled to present at 11:30 AM PT / 2:30 PM ET and will hold one-on-one meetings at the conference.
Investors will be able to download management’s PowerPoint presentations under Events and Presentations in the investor relations section of the company’s website at www.aceto.com.
ABOUT ACETO
ACETO Corporation, incorporated in 1947 and with offices and operations in 10 countries, is engaged in the development, marketing, sale and distribution of Human Health products (finished dosage form generics and nutraceuticals), Pharmaceutical Ingredients (pharmaceutical intermediates and active pharmaceutical ingredients) and Performance Chemicals (specialty chemicals and agricultural protection products).
Investor Relations Contact LHA Jody Burfening [email protected] (212) 838-3777
